Important parameters to consider for the characterization of PET and SPECT imaging probes

Nuclear Medicine and Biology

Volumn 38, Issue 8, 2011, Pages 1079-1084

  Chopra, Arvind ^a   Shan, Liang ^a   Eckelman, William C ^a   Leung, Kam ^a   Menkens, Anne E ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; CONTRAST MEDIUM; FLUORINE 18; IODINE 124; TRACER;

ANALYTIC METHOD; DATA BASE; DRUG PURITY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MOLECULAR IMAGING PROBE; MOLECULAR PROBE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; QUALITY CONTROL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THIN LAYER CHROMATOGRAPHY; UNITED STATES;

ANIMALS; DATABASES, FACTUAL; HUMANS; MICE; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; PRIMATES; RABBITS; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RESEARCH; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 82655181865     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.05.011     Document Type: Editorial

References (9)

1. Cheng K.T., Menkens A., Bryant S., Sullivan D.C. NIH MICAD initiative and guest author program opportunities. J Nucl Med 2007, 19N:48.
2. United States Pharmacopeia Convention I. Radiopharmaceuticals for positron emission tomography-compounding. United States Pharmacopeia General Chapter <823> 2003;24 & National Formulary 19:2213-6.
3. Nakao R., Furutuka K., Yamaguchi M., Suzuki K. Quality control of PET radiopharmaceuticals using HPLC with electrochemical detection. Nucl Med Biol 2006, 33:441-447.
4. Vallabhajosula S. Quality control of PET radiopharmaceuticals. Molecular Imaging: Radiopharmaceuticals for PET and SPECT 2009, 197-204. Springer, Berlin. S. Vallabhajosula (Ed.).
5. Ekins S., Kaneko T., Lipinski C.A., Bradford J., Dole K., Spektor A., et al. Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis. Mol Biosyst 2010, 6:2316-2324.
6. Hopkins A.L., Groom C.R. The druggable genome. Nat Rev Drug Discov 2002, 1:727-730.
7. Reilly R. The immunoreactivity of radiolabeled antibodies-its impact on tumor targeting and strategies for preservation. Cancer Biother Radiopharm 2004, 19:669-672.
8. Pakzad F., Ell P.J., Carrio I. Molecular imaging in animal models of disease-every little detail counts!. Eur J Nucl Med Mol Imaging 2005, 32:899-900.
9. Eckelman W.C., Kilbourn M.R., Joyal J.L., Labiris R., Valliant J.F. Justifying the number of animals for each experiment. Nucl Med Biol 2007, 34:229-232.